Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Risk Hematologic Malignancy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchWithdrawnNCT07123662
What this trial is testing

Γδ T Cell Therapy for Relapse Prevention in High-Risk AML Post-Transplant

Who this might be right for
LeukemiaMyeloidAcute
Guangzhou Bio-gene Technology Co., Ltd
Testing effectiveness (Phase 2)Study completedNCT00113932
What this trial is testing

UARK 2003-41: A Study of High-Dose Density Therapy in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Arkansas 140
Not applicableUnknownNCT05735704
What this trial is testing

Early Detection and Screening of Hematological Malignancies - SANGUINE

Who this might be right for
Hematologic Malignancy
JaxBio Ltd 3,000
Not applicableStudy completedNCT01896752
What this trial is testing

Renal and Hepatic Clearance Following High-Dose Methotrexate in Childhood ALL

Who this might be right for
Lymphoblastic Leukemia, Acute, Childhood
Rigshospitalet, Denmark 43
Testing effectiveness (Phase 2)UnknownNCT02856464
What this trial is testing

Prophylactic DLI for the Prevention of Relapse Post HSCT in Patients With High Risk Myeloid Malignancy

Who this might be right for
Myelodysplastic SyndromesLeukemia, Myeloid, Acute
King's College Hospital NHS Trust 124
Testing effectiveness (Phase 2)Study completedNCT01455051
What this trial is testing

Ofatumumab as Part of Reduced Intensity Conditioning (RIC) Regimen for Patients With High Risk Chronic Lymphocytic Leukemia (CLL) Undergoing Allogeneic Hematopoietic Cell Transplantation

Who this might be right for
Chronic Lymphocytic Leukemia
Grupo Espanol de trasplantes hematopoyeticos y terapia celular 25
Testing effectiveness (Phase 2)Study completedNCT01775553
What this trial is testing

Study of High Dose Carfilzomib in Multiple Myeloma Patients Who Have Progressed On Standard Dose Carfilzomib

Who this might be right for
Relapse Multiple MyelomaRefractory Multiple Myeloma
Ajai Chari 13
Testing effectiveness (Phase 2)Active Not RecruitingNCT05304754
What this trial is testing

"Phase I / II Study on Infusion of Natural Killer Cells After Haploidentical Transplantation in Pediatric Patients"

Who this might be right for
High-risk Leukemias
Instituto de Investigación Hospital Universitario La Paz 18
Early research (Phase 1)Study completedNCT03955783
What this trial is testing

Venetoclax and Selinexor in Treating Patients with Relapsed or Refractory High Risk Hematologic Malignancies

Who this might be right for
Diffuse Large B-cell LymphomaAcute Myeloid LeukemiaNon-Hodgkin's Lymphoma
Sanjay Mohan 78
Not applicableStudy completedNCT07291986
What this trial is testing

To Compare the Clinical Outcomes of FemtoLASIK and ICL Implantation in Treating Moderate Myopia Focusing on Refractive Stability, Contrast Sensitivity and High Order Aberrations.

Who this might be right for
Myopia, Moderate
Walid Osama Abdel Rahman Nour El Din 60
Testing effectiveness (Phase 2)Study completedNCT00003402
What this trial is testing

Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

Who this might be right for
LeukemiaLymphoma
University of Maryland, Baltimore 35
Testing effectiveness (Phase 2)Study completedNCT00003039
What this trial is testing

Flavopiridol in Treating Patients With Recurrent Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma or Mantle Cell Lymphoma

Who this might be right for
Lymphoma
National Cancer Institute (NCI) 40
Large-scale testing (Phase 3)Study completedNCT00750737
What this trial is testing

Oral Posaconazole Three Times Per Day vs Weekly High Dose Amphotericin B Lipid Complex (ABLC)

Who this might be right for
Invasive Fungal InfectionsHematologic Malignancies
M.D. Anderson Cancer Center 46
Early research (Phase 1)Study completedNCT03787498
What this trial is testing

PLX2853 in Relapsed or Refractory Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome

Who this might be right for
Relapsed Acute Myeloid Leukemia (AML)Refractory Acute Myeloid Leukemia (AML)High-risk Myelodysplastic Syndrome (MDS)
Opna Bio LLC 22
Not applicableStudy completedNCT06049511
What this trial is testing

Oral Self Care Protocol and Oral Mucositis

Who this might be right for
Mucositis Oral
Ege University 60
Post-approval studies (Phase 4)Study completedNCT01201811
What this trial is testing

Study of Azacitidine in Adult Taiwanese Subjects With Higher-Risk Myelodysplastic Syndromes (MDS)

Who this might be right for
Myelodysplastic Syndromes
Celgene 44
Testing effectiveness (Phase 2)UnknownNCT01665014
What this trial is testing

Total Marrow Irradiation and High-dose Melphalan for Double Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma

Who this might be right for
Multiple Myeloma
Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice 50
Testing effectiveness (Phase 2)Ended earlyNCT00582816
What this trial is testing

Haploidentical Transplant With NK Cell Infusion for Pediatric Acute Leukemia and Solid Tumors

Who this might be right for
LeukemiaSolid Tumors
University of Wisconsin, Madison 9
Large-scale testing (Phase 3)UnknownNCT01484171
What this trial is testing

HLA-mismatched Microtransplantation for High Risk Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences 50
Large-scale testing (Phase 3)Study completedNCT00483132
What this trial is testing

Study of Treatment High Risk and/or Low Risk Acute Lymphoblastic leukémia(ALL) Adults Stage III

Who this might be right for
Leukemia, Lymphocytic, Acute
French Innovative Leukemia Organisation 232
Next Page